NovAccess Global Inc. (OTCMKTS:XSNX – Get Free Report) was the target of a large decline in short interest in March. As of March 15th, there was short interest totalling 400 shares, a decline of 98.3% from the February 29th total of 24,000 shares. Based on an average daily trading volume, of 972,800 shares, the short-interest ratio is presently 0.0 days.
NovAccess Global Price Performance
XSNX stock opened at $0.01 on Friday. NovAccess Global has a one year low of $0.01 and a one year high of $0.22. The stock has a market cap of $303,000.00, a PE ratio of -0.10 and a beta of 1.57. The firm has a 50 day simple moving average of $0.02 and a two-hundred day simple moving average of $0.04.
NovAccess Global (OTCMKTS:XSNX – Get Free Report) last announced its quarterly earnings data on Tuesday, February 27th. The company reported $0.01 earnings per share for the quarter.
About NovAccess Global
NovAccess Global Inc, a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. It specializes in cutting-edge research related to utilizing a patient's immune system to attack the cancer. The company was incorporated in 1997 and is headquartered in Chagrin Falls, Ohio.
Featured Articles
- Five stocks we like better than NovAccess Global
- How to Use Stock Screeners to Find Stocks
- 3 Value Stocks Too Small For Buffett’s Portfolio
- Industrial Products Stocks Investing
- Foot Locker Builds Up Another Head of Steam; Gains Imminent
- The Role Economic Reports Play in a Successful Investment Strategy
- Disney Stock Catches 3 Upgrades In a Single Week
Receive News & Ratings for NovAccess Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NovAccess Global and related companies with MarketBeat.com's FREE daily email newsletter.
